STAAR Surgical Company ( STAA) - Key Metrics
STAA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.17 | -$0.37 | -$0.08 | -$0.11 |
| 2025Q4 | $1.91 | $0.18 | $0.05 | $0.04 |
| 2025Q3 | $1.91 | $0.18 | $0.05 | $0.04 |
| 2025Q3 | $1.91 | $0.18 | $0.05 | $0.04 |
STAA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -15.97 |
| 2025Q4 | ? | 35.19 |
| 2025Q3 | ? | 37.35 |
| 2025Q3 | ? | 37.65 |
STAA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.19% | ? |
| 2025Q4 | -0.48% | ? |
| 2025Q4 | 0.14% | ? |
| 2025Q3 | 0.13% | ? |
| 2025Q3 | 0.13% | ? |
STAA
Price: $28.37
52 week price:
Earnings Per Share: -0.42 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 638969
Ebitda: 1.9 millionMarket Capitalization: 1.5 billion